Habeners remarkable scientific achievements were recognized internationally, including his receipt of the 2019 Harold Hamm award, the 2021 Gairdner award, the 2024 Lasker-DeBakey Clinical Medical Research Award, shared with colleagues for their collective contributions to GLP1based therapeutics
no tumor vs
Induction of cytotoxicity through photorelease of aminoferrocene
Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM
It is important to recognise that patients prescribed GLP-1 agonists often have underlying conditionssuch as type 2 diabetes, obesity, hypertension, and dyslipidaemiathat independently increase cardiovascular and thrombotic risk